{"title":"Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome","authors":"Saranchina Yuliya Vladimirovna, Rossova N. Aleksandrovna, Khanarin Nikolaj Vladimirovich, Kilina Oksana Yurevna, Dutova Svetlana Vyacheslavovna, Kulakova Tatyana Sergeevna","doi":"10.2174/1875692117666190416150346","DOIUrl":null,"url":null,"abstract":"\n\nThe purpose of the study was to analyze the association of allelic\npolymorphism of IL1В gene C>T loci -31 and +3953 with atherosclerotic changes of\nartries in patients with Metabolic Syndrome (MS).\n\n\n\nThe main group of the study included 30 consecutive patients\n(24 women and 6 men, mean age - 51.7±2.2 years), for examination and treatment in the\ntherapeutic Department of the Republican clinical hospital named \"G. YA. Remishevskaya\"\n(Abakan) about arterial hypertension or suspicion of type 2 diabetes. The criteria for inclusion\nin the core group included: compliance with the MS criteria according to the IDF criteria\n(2006); and the presence of ultrasound markers of Atherosclerosis (AS) according to\nthe study of brachiocephalic arteries (presence of Atherosclerotic Plaques (ASP) and\nstenosis ≥30%). The control group included persons who underwent a planned medical\nexamination in the Republican clinical hospital name \"G. YA. Remishevskaya\" (Abakan).\nA total of 35 patients (26 women and 9 men, mean age 44.7±1.5 years) were selected. The\nstudy involved the Russian population (Caucasians) living in the territory of the Republic\nof Khakassia. All the necessary examination and data collection were conducted including\nanamnestic data, anthropometric examination (measurements of length and body mass,\nwaist circumference) body mass index, laboratory examination of blood biochemical parameters\n(glucose and lipid) and instrumental examination (blood pressure measurement,\nconducting ECG and ultrasound the brachiocephalic arteries). Single-nucleotide polymorphisms\n(SNP) of the promoter region of the IL1B gene at position-31C/T (rs1143627) and\npolymorphism in the coding part of the gene in exon 5 +3953C/T (rs 1143634) were studied\nby restriction analysis of amplification products (RFLP analysis).\n\n\n\nThe risk of development of AS in patients with MS may be higher in carriers of\ngenotype TT (OR = 1,76; 95% CI: (0,96-3,24)) or T allele (OR = 1,44; 95% CI: (0,82-\n2,53)) IL1В gene in the polymorphic locus of the T-31С and genotype CT (OR = 1,85;\n95% CI: (0,92-3,37)) or T allele (OR = 1,35; 95% CI: (0,63-2,89)) IL1В gene in the\npolymorphic locus of C + 3953T. The most common combination of gene polymorphisms\nIL1В was haplotype (-31) ТC/(+3953)СС in both the groups surveyed (40.6% to 36.8%,\nrespectively). Variant (-31)TT/(+3953)CT in the main group was found significantly more\noften (15.8%, at χ2= 4.92, at p=0.03) than in the control group (3.1 %). The value of the\nodds ratio in this case was 3.99 (95% CI: (1.08-14.79), which indicates the risk of AS development\nagainst the background of MS in carriers of combined genotype inheritance\n(-31)TT/(+3953) CT.\n\n\n\nThe risk of development of AS in the background of MS is increased in\ncarriers of combinations of SNPs (-31)TT/(+3953)CT IL1В gene responsible for hyperproduction\nof this cytokine. In this connection, further studies of the association of genes\nwith MS and AS components should focus on intergenic interactions.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"26 1","pages":"32-39"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692117666190416150346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
The purpose of the study was to analyze the association of allelic
polymorphism of IL1В gene C>T loci -31 and +3953 with atherosclerotic changes of
artries in patients with Metabolic Syndrome (MS).
The main group of the study included 30 consecutive patients
(24 women and 6 men, mean age - 51.7±2.2 years), for examination and treatment in the
therapeutic Department of the Republican clinical hospital named "G. YA. Remishevskaya"
(Abakan) about arterial hypertension or suspicion of type 2 diabetes. The criteria for inclusion
in the core group included: compliance with the MS criteria according to the IDF criteria
(2006); and the presence of ultrasound markers of Atherosclerosis (AS) according to
the study of brachiocephalic arteries (presence of Atherosclerotic Plaques (ASP) and
stenosis ≥30%). The control group included persons who underwent a planned medical
examination in the Republican clinical hospital name "G. YA. Remishevskaya" (Abakan).
A total of 35 patients (26 women and 9 men, mean age 44.7±1.5 years) were selected. The
study involved the Russian population (Caucasians) living in the territory of the Republic
of Khakassia. All the necessary examination and data collection were conducted including
anamnestic data, anthropometric examination (measurements of length and body mass,
waist circumference) body mass index, laboratory examination of blood biochemical parameters
(glucose and lipid) and instrumental examination (blood pressure measurement,
conducting ECG and ultrasound the brachiocephalic arteries). Single-nucleotide polymorphisms
(SNP) of the promoter region of the IL1B gene at position-31C/T (rs1143627) and
polymorphism in the coding part of the gene in exon 5 +3953C/T (rs 1143634) were studied
by restriction analysis of amplification products (RFLP analysis).
The risk of development of AS in patients with MS may be higher in carriers of
genotype TT (OR = 1,76; 95% CI: (0,96-3,24)) or T allele (OR = 1,44; 95% CI: (0,82-
2,53)) IL1В gene in the polymorphic locus of the T-31С and genotype CT (OR = 1,85;
95% CI: (0,92-3,37)) or T allele (OR = 1,35; 95% CI: (0,63-2,89)) IL1В gene in the
polymorphic locus of C + 3953T. The most common combination of gene polymorphisms
IL1В was haplotype (-31) ТC/(+3953)СС in both the groups surveyed (40.6% to 36.8%,
respectively). Variant (-31)TT/(+3953)CT in the main group was found significantly more
often (15.8%, at χ2= 4.92, at p=0.03) than in the control group (3.1 %). The value of the
odds ratio in this case was 3.99 (95% CI: (1.08-14.79), which indicates the risk of AS development
against the background of MS in carriers of combined genotype inheritance
(-31)TT/(+3953) CT.
The risk of development of AS in the background of MS is increased in
carriers of combinations of SNPs (-31)TT/(+3953)CT IL1В gene responsible for hyperproduction
of this cytokine. In this connection, further studies of the association of genes
with MS and AS components should focus on intergenic interactions.
期刊介绍:
Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.